1 Study Coverage
1.1 Cancer (Tumor) Profiling Revenue in Cancer (Tumor) Profiling Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cancer (Tumor) Profiling Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer (Tumor) Profiling Market Size for the Year 2017-2028
1.2.2 Global Cancer (Tumor) Profiling Market Size for the Year 2017-2028
1.3 Cancer (Tumor) Profiling Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cancer (Tumor) Profiling in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cancer (Tumor) Profiling Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cancer (Tumor) Profiling Market Dynamics
1.4.1 Cancer (Tumor) Profiling Industry Trends
1.4.2 Cancer (Tumor) Profiling Market Drivers
1.4.3 Cancer (Tumor) Profiling Market Challenges
1.4.4 Cancer (Tumor) Profiling Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cancer (Tumor) Profiling by Type
2.1 Cancer (Tumor) Profiling Market Segment by Type
2.1.1 Immunoassay
2.1.2 NGS
2.1.3 Mass Spectrometry
2.1.4 Others
2.2 Global Cancer (Tumor) Profiling Market Size by Type (2017, 2022 & 2028)
2.3 Global Cancer (Tumor) Profiling Market Size by Type (2017-2028)
2.4 United States Cancer (Tumor) Profiling Market Size by Type (2017, 2022 & 2028)
2.5 United States Cancer (Tumor) Profiling Market Size by Type (2017-2028)
3 Cancer (Tumor) Profiling by Application
3.1 Cancer (Tumor) Profiling Market Segment by Application
3.1.1 Clinical
3.1.2 Research
3.2 Global Cancer (Tumor) Profiling Market Size by Application (2017, 2022 & 2028)
3.3 Global Cancer (Tumor) Profiling Market Size by Application (2017-2028)
3.4 United States Cancer (Tumor) Profiling Market Size by Application (2017, 2022 & 2028)
3.5 United States Cancer (Tumor) Profiling Market Size by Application (2017-2028)
4 Global Cancer (Tumor) Profiling Competitor Landscape by Company
4.1 Global Cancer (Tumor) Profiling Market Size by Company
4.1.1 Top Global Cancer (Tumor) Profiling Companies Ranked by Revenue (2021)
4.1.2 Global Cancer (Tumor) Profiling Revenue by Player (2017-2022)
4.2 Global Cancer (Tumor) Profiling Concentration Ratio (CR)
4.2.1 Cancer (Tumor) Profiling Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer (Tumor) Profiling in 2021
4.2.3 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer (Tumor) Profiling Headquarters, Revenue in Cancer (Tumor) Profiling Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cancer (Tumor) Profiling Headquarters and Area Served
4.3.2 Global Cancer (Tumor) Profiling Companies Revenue in Cancer (Tumor) Profiling Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cancer (Tumor) Profiling Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer (Tumor) Profiling Market Size by Company
4.5.1 Top Cancer (Tumor) Profiling Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer (Tumor) Profiling Revenue by Players (2020, 2021 & 2022)
5 Global Cancer (Tumor) Profiling Market Size by Region
5.1 Global Cancer (Tumor) Profiling Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer (Tumor) Profiling Market Size by Region (2017-2028)
5.2.1 Global Cancer (Tumor) Profiling Market Size by Region: 2017-2022
5.2.2 Global Cancer (Tumor) Profiling Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer (Tumor) Profiling Market Size YoY Growth 2017-2028
6.1.2 North America Cancer (Tumor) Profiling Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer (Tumor) Profiling Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer (Tumor) Profiling Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer (Tumor) Profiling Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer (Tumor) Profiling Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer (Tumor) Profiling Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer (Tumor) Profiling Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer (Tumor) Profiling Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer (Tumor) Profiling Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Company Details
7.1.2 Illumina Business Overview
7.1.3 Illumina Cancer (Tumor) Profiling Introduction
7.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.1.5 Illumina Recent Development
7.2 Qiagen
7.2.1 Qiagen Company Details
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Cancer (Tumor) Profiling Introduction
7.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.2.5 Qiagen Recent Development
7.3 Neogenomics Laboratories
7.3.1 Neogenomics Laboratories Company Details
7.3.2 Neogenomics Laboratories Business Overview
7.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
7.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.3.5 Neogenomics Laboratories Recent Development
7.4 HTG Molecular Diagnostics
7.4.1 HTG Molecular Diagnostics Company Details
7.4.2 HTG Molecular Diagnostics Business Overview
7.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
7.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.4.5 HTG Molecular Diagnostics Recent Development
7.5 Genomic Health
7.5.1 Genomic Health Company Details
7.5.2 Genomic Health Business Overview
7.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
7.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.5.5 Genomic Health Recent Development
7.6 Caris Life Sciences
7.6.1 Caris Life Sciences Company Details
7.6.2 Caris Life Sciences Business Overview
7.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
7.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.6.5 Caris Life Sciences Recent Development
7.7 Helomics Corporation
7.7.1 Helomics Corporation Company Details
7.7.2 Helomics Corporation Business Overview
7.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
7.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.7.5 Helomics Corporation Recent Development
7.8 Nanostring Technologies
7.8.1 Nanostring Technologies Company Details
7.8.2 Nanostring Technologies Business Overview
7.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
7.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.8.5 Nanostring Technologies Recent Development
7.9 Oxford Gene Technology
7.9.1 Oxford Gene Technology Company Details
7.9.2 Oxford Gene Technology Business Overview
7.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
7.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.9.5 Oxford Gene Technology Recent Development
7.10 Ribomed Biotechnologies
7.10.1 Ribomed Biotechnologies Company Details
7.10.2 Ribomed Biotechnologies Business Overview
7.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
7.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2017-2022)
7.10.5 Ribomed Biotechnologies Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
